Inventor · disambiguated record
Christopher B. Newgard
Also filed as: NEWGARD CHRISTOPHER B
14 granted patents·7 pending applications·464 citations·filing 1992–2019
94Inventor score
Top patents by PatentIndex Score
21 records- 0188US6110707ARecombinant expression of proteins from secretory cell linesUNIV TEXAS·Filed 1997·Granted Aug 29, 2000·88 cites·41 claims
- 0286US5854067AHexokinase inhibitorsUNIV TEXAS·Filed 1996·Granted Dec 29, 1998·96 cites·64 claims
- 0384US6087129ARecombinant expression of proteins from secretory cell linesBETAGENE INC·Filed 1996·Granted Jul 11, 2000·76 cites·26 claims
- 0482US6194176B1Recombinant expression of proteins from secretory cell linesUNIV TEXAS·Filed 1997·Granted Feb 27, 2001·43 cites·59 claims
- 0578US5427940AEngineered cells producing insulin in response to glucoseUNIV TEXAS·Filed 1992·Granted Jun 27, 1995·42 cites·22 claims
- 0675US5891717AMethods and compositions for inhibiting hexokinaseBETAGENE INC·Filed 1996·Granted Apr 6, 1999·49 cites·79 claims
- 0770US8889639B2Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disordersSPIEGELMAN BRUCE M·Filed 2005·Granted Nov 18, 2014·1 cites·38 claims
- 0856US5811266AMethods for producing human insulinUNIV TEXAS·Filed 1994·Granted Sep 22, 1998·15 cites·25 claims
- 0955US2021267939A1Compositions and methods for treating nafld/nash and related disease phenotypesUNIV DUKE·Filed 2019·Application pending·0 cites
- 1055US2021349103A1Metabolic biomarkers of nafld/nash and related disease phenotypes and methods of using sameUNIV DUKE·Filed 2019·Application pending·0 cites
- 1153US5747325ADevices comprising genetically engineered βcellsUNIV TEXAS·Filed 1995·Granted May 5, 1998·15 cites·29 claims
- 1250US6171856B1Methods and compositions relating to no-mediated cytotoxicityUNIV TEXAS·Filed 1998·Granted Jan 9, 2001·20 cites·4 claims
- 1348US5744327AMethods for producing insulin in response to non-glucose secretagoguesUNIV TEXAS·Filed 1992·Granted Apr 28, 1998·11 cites·37 claims
- 1447US2014315984A1Methods and Compositions for Treatment of Diabetes and Related DisordersUNIV DUKE·Filed 2014·Application pending·0 cites
- 1546US2007243177A1Methods and compositions for treatment of diabetes and related disordersUNIV DUKE·Filed 2007·Application pending·0 cites
- 1646US2004180845A1Methods and compositions for modulating glycogen synthesis and breakdownFiled 2003·Application pending·0 cites
- 1741US10317414B2Predicting coronary artery disease and risk of cardiovascular eventsUNIV DUKE·Filed 2016·Granted Jun 11, 2019·0 cites·16 claims
- 1839US5792656AMethods of preparing genetically engineered cells that produce insulin in response to glucoseUNIV TEXAS·Filed 1995·Granted Aug 11, 1998·8 cites·50 claims
- 1939US2011318726A1Predicting coronary artery disease and risk of cardiovascular eventsSHAH SVATI H·Filed 2010·Application pending·0 cites
- 2035US2002141979A1Methods and compositions for STAT-1 conferred resistance to immunotoxicityFiled 2001·Application pending·0 cites
- 2134US8580732B2Peptide therapy for hyperglycemiaNEWGARD CHRISTOPHER B·Filed 2010·Granted Nov 12, 2013·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Christopher B. Newgard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →